Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Establishment Labs Holdings Inc (ESTA)

Establishment Labs Holdings Inc (ESTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Establishment Labs Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025 Business Wire - Mon Jan 12, 7:00AM CST

Revenue for the quarter ended December 31, 2025 is expected to be between $64.0 million and $65.0 million, including between $17.0 million and $17.5 million from Motiva sales in the United States. ...

ESTA : 65.13 (-2.44%)
Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference Business Wire - Wed Dec 31, 2025

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 65.13 (-2.44%)
Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction Business Wire - Mon Dec 29, 2025

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 65.13 (-2.44%)
Establishment Labs to Present at Jefferies London Healthcare Conference Business Wire - Fri Nov 7, 2025

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 65.13 (-2.44%)
Establishment Labs Reports Third Quarter 2025 Financial Results Business Wire - Wed Nov 5, 2025

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 65.13 (-2.44%)
Establishment Labs to Announce Third Quarter 2025 Financial Results on November 5 Business Wire - Wed Oct 22, 2025

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to...

ESTA : 65.13 (-2.44%)
Canaccord Genuity Keeps Their Buy Rating on Establishment Labs Holdings (ESTA) Tipranks - Thu Oct 16, 2025

In a report released yesterday, Caitlin Cronin from Canaccord Genuity reiterated a Buy rating on Establishment Labs Holdings, with a price target of $60.00. The company’s shares closed yesterday at $44.40.Elevate...

ESTA : 65.13 (-2.44%)
Establishment Labs Notes Publication of Mia Femtech 3-Year Prospective Study Results in Aesthetic Surgery Journal Business Wire - Tue Oct 14, 2025

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, noted the...

ESTA : 65.13 (-2.44%)
Establishment Labs Publishes 15 Years of Motiva Data in 2025 Post-Market Surveillance Report Business Wire - Thu Oct 9, 2025

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced...

ESTA : 65.13 (-2.44%)
Citi Sticks to Its Hold Rating for Establishment Labs Holdings (ESTA) Tipranks - Wed Oct 8, 2025

In a report released on October 3, Joanne Wuensch from Citi maintained a Hold rating on Establishment Labs Holdings, with a price target of $43.00. The company’s shares closed yesterday at $39.33.Elevate...

ESTA : 65.13 (-2.44%)

Barchart Exclusives

Should You Buy Dividend-Paying Gold Stocks as Trump Makes Them ‘Great Again’? Barchart - Tue Jan 13, 6:30PM CST
Gold stocks have soared over the last year amid the rally in gold prices. Miners are paying handsome dividends as their cash flows have tracked gold prices higher. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot